| Craig A. Wheeler |
Wheeler joined Momenta as CEO in September of 2006. He led the company
through the launch of its first complex drug products, including the
first generic versions of LOVENOX® and COPAXONE®. In 2011, he was
an E&Y Entrepreneur of the Year Regional Award winner. In May 2012,
the Boston Globe named Momenta the number one company in their
annual Globe 100 survey of top performing companies. Prior to joining
Momenta, Wheeler was president of Chiron BioPharmaceuticals where
during his five-year tenure the pharmaceutical division’s global sales more
than doubled. Before that, he was a senior member of The Boston Consulting
Group’s health care practice. He began his career at Merck’s MSDRL
research unit. Wheeler is currently a member of the board of directors of
Amicus Therapeutics as well as the Association for Accessible Medicines
where he previously served as chairman from 2014 to 2016. He also previously
served as the chairman of the board of Avanir Pharmaceuticals.
301 Binney Street
Cambridge, MA 02142
617 395-5158
Craig_wheeler@comcast.net